Karyopharm Therapeutics Inc. - Common Stock (KPTI)

6.3450
+0.4550 (7.72%)
NASDAQ · Last Trade: Apr 6th, 11:10 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026